๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Predictors of length of stay for pediatric liver transplant recipients

โœ Scribed by John C. Bucuvalas; Lan Zeng; Ravinder Anand


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
131 KB
Volume
10
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

โœฆ Synopsis


The resources that are directed towards the care of liver transplant recipients are substantial. Approximately 100 million dollars are spent on the hospitalization of the 400 -500 children in the United States who undergo liver transplantation each year. Using length of stay as a surrogate marker for hospital resource use, we sought to identify factors that impact length of stay and assess the trends of hospitalization after liver transplantation for a representative population of pediatric liver transplant recipients. The study population was comprised of 956 patients who underwent primary liver transplantation between 1995 and 2003 and survived at least 90 days. Data were retrieved from the Studies of Pediatric Liver Transplantation data registry. The primary outcome was the length of initial hospitalization after liver transplantation. Independent variables were age, gender, race, pediatric endstage liver disease score (PELD), year of transplantation, organ type, primary disease, length of operation, and insurance status. The mean and standard deviation of length of stay after liver transplantation was 24.0 ุŽ 24.5 days. Multivariate analyses showed that increased hospital stay was associated with infants less than 1 year of age, fulminant liver failure, receiving a technical variant organ from a cadaveric donor, government insurance, and transplant era (before 1999 vs. 1999 or later). Decreasing height z-scores and increasing length of operation were also associated with increased hospital stay. In conclusion, these parameters accounted for only 11% of the total variance, suggesting that post-transplant complications and course account for much of the variability of resource use in the immediate post-transplant period. Supplementary material for this article can be found on the LIVER TRANSPLANTATION website (http://www.interscience.wiley. com/jpages/1527-6465/suppmat).


๐Ÿ“œ SIMILAR VOLUMES


Survival among pediatric liver transplan
โœ Peter L. Abt; Rachel Rapaport-Kelz; Niraj M. Desai; Adam Frank; Seema Sonnad; El ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 103 KB

Segmental liver transplantation with living donor (LD), reduced cadaveric (Reduced), and split cadaveric (Split) allografts has expanded the availability of size-appropriate organs for pediatric recipients. The relevance of recipient age to the selection of graft type has not been fully explored, bu

Factors influencing liver transplant len
โœ W. Kenneth Washburn; Nicholas A. Meo; Glenn A. Halff; John P. Roberts; Sandy Fen ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 162 KB ๐Ÿ‘ 1 views

Length of stay (LOS) is considered a reliable surrogate for liver transplant resource utilization. Little information exists about how donor and recipient variables interact to affect transplant LOS. Data for adult, non-status 1 transplants (1998-2005), including the donor risk index (DRI) and Model

Quality of life for pediatric liver reci
โœ Estella M. Alonso ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 239 KB ๐Ÿ‘ 1 views

1. The measurement of health-related quality of life (HRQOL) in children must be performed with instruments that are sensitive to developmental changes and that include assessments of domains of function that are specific to childhood. 2. Pediatric liver transplant recipients report HRQOL outcomes t

Allograft rejection in pediatric recipie
โœ E M Alonso; J B Piper; G Echols; J R Thistlethwaite; P F Whitington ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 145 KB ๐Ÿ‘ 1 views

The purpose of this study was to compare the inci-dence and severity of rejection episodes in a group of dence and severity of rejection episodes in a group of children receiving living related orthotopic liver transchildren receiving living related orthotopic liver transplants (LRLT) versus patient

The pediatric end-stage liver disease (P
โœ Neal R. Barshes; Timothy C. Lee; Ian W. Udell; Christine A. O'Mahoney; Saul J. K ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 190 KB ๐Ÿ‘ 1 views

The pediatric end-stage liver disease (PELD) model accurately estimates 90-day waitlist mortality for pediatric liver transplant candidates, but it has been unclear if PELD can identify patients who will derive survival benefit from undergoing liver transplantation (LT), if it correlates with posttr

The natural history of hepatitis C virus
โœ Neal R. Barshes; Ian W. Udell; Timothy C. Lee; Christine A. O'Mahony; Saul J. Ka ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 159 KB ๐Ÿ‘ 1 views

Although rare in the pediatric population, the natural history of hepatitis C virus (HCV) recurrence in pediatric patients undergoing orthotopic liver transplantation (OLT) for end-stage liver disease secondary to HCV has not been well described. We performed an analysis of all 67 pediatric patients